Immunotherapy, a form of treatment that uses the body’s immune system to find and fight cancer cells, can delay the...
ZyVersa Therapeutics (NASDAQ: ZVSA) announces CEO Stephen C. Glover's attendance at JPM's 43rd Annual Healthcare...
HLB logo. On 16 May this year, the FDA issued a Complete Response Letter (CRL) requesting...
A Travere Therapeutics drug for a rare disease that can progress to kidney failure has converted its status to full...
Register for free to listen to this article Thank you. Listen to this article using the player above. ✖...
Bausch Health Companies Inc. along with its gastroenterology business, Salix Pharmaceuticals, Inc., has filed a lawsuit in the United States...
